Safety and Pharmacokinetics of Ifetroban in Hepatorenal Syndrome Patients

Clinical trial NCT01436500 · COMPLETED

Trial details

NCT number: NCT01436500
Sponsor: Cumberland Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Hepatorenal Syndrome

Start date: 2011-10-01
Primary completion: 2015-06-01
Enrollment: 55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.